Local recurrence of rectal cancer: Evaluation with F-18 fluorodeoxyglucose PET imaging

Abdominal Imaging

Volumn 22, Issue 3, 1997, Pages 332-337

  Keogan, M T ^a   Lowe, V J ^a,b   Baker, M E ^a,c   McDermott, V G ^a   Lyerly, H K ^a   Coleman, R E ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b S LOUIS UNIV HLTH SCIENCES CENTER   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Colon; Emission CT; Neoplasm

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM CANCER;

DEOXYGLUCOSE; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0030942995     PISSN: 09428925     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002619900202     Document Type: Article

References (35)

1. Olson RM, Perencevich NP, Malcolm AW, et al. Patterns of recurrence following curative resection of adenocarcinoma of the colon and rectum. Cancer 1980;45:2969-2974
2. Pilipshen SJ, Heilweil M, Quan SHQ, et al. Patterns of pelvic recurrence following definitive resections of rectal cancer. Cancer 1984;53:1354-1362
3. Stulc JP, Petrelli NJ, Herrera L, et al. Anastomotic recurrence of adenocarcinoma of the colon. Arch Surg 1986;121:1077-1080
4. Quentmeier A, Schlag P, Smok M, et al. Re-operation for recurrent colorectal cancer: the importance of early diagnosis for resectability and survival. Eur J Surg Oncol 1990;16:319-325
5. Himal HS. Anastomotic recurrence of carcinoma of the colon and rectum. The value of endoscopy and serum CEA levels. Am Surg 1991;5:334-336
6. Freeny PC, Marks WM, Ryan JA, et al. Colorectal carcinoma evaluation with CT: preoperative staging and detection of post-operative recurrence. Radiology 1986;158:347-353
7. Moss AA. Imaging of colorectal carcinoma. Radiology 1989; 170:308-310
8. Moss AA, Thoeni RF, Schnyder P, et al. Value of computed tomography in the detection and staging of recurrent rectal carcinomas. J Comput Assist Tomogr 1981;5:870-874
9. Chen YM, Ott DJ, Wolfman NT, et al. Recurrent colorectal carcinoma: evaluation with barium enema examination and CT. Radiology 1987;163:307-310
10. de Lange EE, Fechner RE, Wanebo HJ. Suspected recurrent rectosigmoid carcinoma after abdominoperineal resection: MR imaging and histopathologic findings. Radiology 1989;170:323-328
11. Krestin GP, Steinbrich W, Friedmann G. Recurrent rectal cancer: diagnosis with MR imaging versus CT. Radiology 1988;168:307-311
12. Muller-Schimpfle M, Brix G, Layer G, et al. Recurrent rectal cancer: diagnosis with dynamic MR imaging. Radiology 1993; 189:881-889
13. Balzarini L, Ceglia E, D'Ippolito G, et al. Local recurrence of rectosigmoid cancer: what about the choice of MRI for diagnosis? Gastrointest Radiol 1990;15:338-342
14. Reznek RH, White FE, Young JWR, et al. The appearances on computed tomography after abdomino-perineal resection for carcinoma of the rectum: a comparison between the normal appearances and those of recurrence. Br J Radiol 1983;56:237-240
15. Husband JE, Hodson NJ, Parsons CA. The use of computed tomography in recurrent rectal tumors. Radiology 1980;134:677-682
16. Butch RJ, Wittenberg J, Mueller PR, et al. Presacral masses after abdominoperineal resection for colorectal carcinoma: the need for needle biopsy. AJR 1985;144:309-312
17. Rafto SE, Amendola MA, Gefter WB. MR imaging of recurrent colorectal carcinoma versus fibrosis. J Comput Assist Tomogr 1988;12:521-523
18. Warburg O. The metabolism of tumors. New York, Richard R. Smith, 1931:129-169
19. Som P, Atkins HL, Bandoypadhyay D, et al. A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): nontoxic tracer for rapid tumor detection. J Nucl Med 1980;21:670-675
20. Wahl RL, Hutchins GD, Buchsbaum DJ, et al. 18F-2-deoxy-2-fluoro-D-glucose uptake into human tumor xenografts. Cancer 1991;67:1544-1550
21. Wahl RL, Cody RL, Hutchins GD, et al. Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1991;179:765-770
22. Bares R, Klever P, Hauptmann S, et al. F-18 fluorodeoxyglucose PET in-vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer. Radiology 1994;192:79-86
23. Boland GW, Goldberg MA, Lee MJ, et al. Indeterminate adrenal mass in patients with cancer: evaluation at PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1995;194:131-134
24. Newman JS, Francis IR, Kaminski MS, et al. Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-d-glucose: correlation with CT. Radiology 1994;190:111-116
25. Yonekura Y, Benua RS, Brill AB, et al. Increased accumulation of 2-deoxy-2-[18F]fluoro-D-glucose in liver metastases from colon carcinoma. J Nucl Med 1982;23:1133-1137
26. Patz EF, Lowe VJ, Hoffman JM, et al. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 1993;188:487-490
27. Ito K, Kato T, Tadokoro M, et al. Recurrent rectal cancer and scar: differentiation with PET and MR imaging. Radiology 1992;182:549-552
28. Strauss LG, Clorius JH, Schlag P, et al. Recurrence of colorectal tumors: PET evaluation. Radiology 1989;170:329-332
29. Lowe VJ, Hoffman JM, DeLong DM, et al. Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities. J Nucl Med 1994;35:1771-1776
30. Carson RE, Daube-Witherspoon, Green MV. A method for post-injection PET transmission measurements with a rotating source. J Nucl Med 1988;29:1558-1567
31. Harnacher K, Coenen HH, Stocklin G. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluror-2-deoxy-D-glucose using aminopolyether-supported nucleophilic substitution. J Nucl Med 1986;27:235-238
32. Di Chiro G, Books RA. PET quantitation: blessing and curse. J Nucl Med 1988;29:1603-1604
33. Alavi JB, Alavi A, Chawluk J, et al. Positron emission tomography inpatients with glioma: a predictor of prognosis. Cancer 1988;62:1074-1078
34. Wahl RL, Quint LE, Cieslak RD, et al. "Anatometabolic" tumor imaging: fusion of FDG-PET with CT or MRI to localize foci of increased activity. J Nucl Med 1993;34:1190-1197
35. Tahara T, Ichiya Y, Kuwabara Y, et al. High [18F]-fluorodeoxy-glucose uptake in abdominal abscesses: a PET study. J Comput Assist Tomogr 1989;13:829-831